News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
852,936 Results
Type
Article (86880)
Company Profile (704)
Press Release (765350)
Multimedia
Podcasts (147)
Webinars (19)
Section
Business (232819)
Career Advice (4133)
Deals (39763)
Drug Delivery (129)
Drug Development (91109)
Employer Resources (198)
FDA (18186)
Job Trends (17364)
News (396849)
Policy (39825)
Tag
Academia (3002)
Academic (2)
Accelerated approval (12)
Adcomms (32)
Allergies (106)
Alliances (56975)
ALS (119)
Alzheimer's disease (1571)
Antibody-drug conjugate (ADC) (187)
Approvals (18140)
Artificial intelligence (401)
Autoimmune disease (37)
Automation (19)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (136)
Biotechnology (482)
Bladder cancer (100)
Brain cancer (41)
Breast cancer (392)
Cancer (3094)
Cardiovascular disease (249)
Career advice (3542)
Career pathing (34)
CAR-T (209)
CDC (41)
Cell therapy (576)
Cervical cancer (24)
Clinical research (74320)
Collaboration (1111)
Company closure (3)
Compensation (711)
Complete response letters (34)
COVID-19 (2904)
CRISPR (67)
C-suite (357)
Cystic fibrosis (121)
Data (3093)
Decentralized trials (2)
Denatured (51)
Depression (77)
Diabetes (380)
Diagnostics (6980)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (183)
Drug pricing (152)
Drug shortages (36)
Duchenne muscular dystrophy (134)
Earnings (97522)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (131474)
Executive appointments (909)
FDA (19930)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1019)
Gene editing (147)
Generative AI (40)
Gene therapy (438)
GLP-1 (937)
Government (5263)
Grass and pollen (6)
Guidances (181)
Healthcare (20917)
HIV (45)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (185)
Immuno-oncology (10)
Indications (40)
Infectious disease (3101)
Inflammatory bowel disease (165)
Inflation Reduction Act (13)
Influenza (71)
Intellectual property (125)
Interviews (813)
IPO (17906)
IRA (55)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (56)
Layoffs (592)
Leadership (27)
Legal (10137)
Liver cancer (85)
Longevity (12)
Lung cancer (433)
Lymphoma (216)
Machine learning (11)
Management (65)
Manufacturing (447)
MASH (99)
Medical device (14730)
Medtech (14735)
Mergers & acquisitions (22584)
Metabolic disorders (968)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (142)
Neuropsychiatric disorders (42)
Neuroscience (2327)
NextGen: Class of 2025 (7687)
Non-profit (5090)
Now hiring (48)
Obesity (496)
Opinion (291)
Ovarian cancer (104)
Pain (121)
Pancreatic cancer (125)
Parkinson's disease (201)
Partnered (25)
Patents (320)
Patient recruitment (173)
Peanut (55)
People (65725)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22938)
Phase II (32270)
Phase III (24298)
Pipeline (1703)
Policy (243)
Postmarket research (3552)
Preclinical (10359)
Press Release (72)
Prostate cancer (150)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (526)
Real estate (7402)
Recruiting (76)
Regulatory (27183)
Reports (61)
Research institute (2666)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (10)
RSV (58)
Schizophrenia (98)
Series A (173)
Series B (118)
Service/supplier (30)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4305)
State (2)
Stomach cancer (17)
Supply chain (84)
Tariffs (65)
The Weekly (94)
Vaccines (918)
Venture capital (58)
Weight loss (332)
Women's health (52)
Worklife (20)
Date
Today (102)
Last 7 days (407)
Last 30 days (2107)
Last 365 days (34083)
2025 (18475)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1273)
Alabama (70)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50540)
Australia (8878)
California (7799)
Canada (2417)
China (727)
Colorado (340)
Connecticut (348)
Delaware (205)
Europe (115947)
Florida (1157)
Georgia (264)
Hawaii (2)
Idaho (66)
Illinois (742)
India (33)
Indiana (386)
Iowa (18)
Japan (239)
Kansas (116)
Kentucky (33)
Louisiana (18)
Maine (73)
Maryland (1105)
Massachusetts (5967)
Michigan (276)
Minnesota (485)
Mississippi (3)
Missouri (101)
Montana (32)
Nebraska (26)
Nevada (83)
New Hampshire (73)
New Jersey (2192)
New Mexico (31)
New York (2187)
North Carolina (1247)
North Dakota (10)
Northern California (3361)
Ohio (252)
Oklahoma (17)
Oregon (48)
Pennsylvania (1663)
Puerto Rico (18)
Rhode Island (39)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2887)
Tennessee (129)
Texas (1197)
United States (29453)
Utah (231)
Virginia (213)
Washington D.C. (80)
Washington State (690)
West Virginia (4)
Wisconsin (86)
There are 852,936 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025
July 16, 2025
·
1 min read
Press Releases
Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook
July 16, 2025
·
20 min read
Press Releases
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2025
July 16, 2025
·
3 min read
Podcast
FDA Layoffs, 200 Rejection Letters, User Fees and Priority Vouchers, Bad Week for Rare Disease
Around 3,500 FDA employees received termination emails; FDA Commissioner Marty Makary suggests lowering industry user fees and tying review times to drug prices; the regulator opens its trove of complete response letters in the name of transparency; and two companies receive rejections for rare disease therapies.
July 16, 2025
·
1 min read
·
Heather McKenzie
Press Releases
Piccolo Medical, Inc. Receives FDA Clearance for 2nd Generation SmartPICC® technology
July 16, 2025
·
3 min read
Career Advice
When Feedback Feels Off: Using Critique That Doesn’t Feel Fair
It’s easy to get caught up in defending yourself against critique that feels unfair. Leadership coach Angela Justice recommends a different approach that can help you better align how you want to be seen with how you’re showing up.
July 16, 2025
·
3 min read
·
Angela Justice
Press Releases
Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration
July 16, 2025
·
6 min read
Press Releases
Evox Therapeutics Expands Scientific Advisory Board
July 16, 2025
·
2 min read
Press Releases
Hemogenyx Awarded Grant
July 16, 2025
·
3 min read
Press Releases
Berlin Heals Announces Publication of Two-Year Clinical Outcomes of Cardiac Microcurrent Therapy in ESC Heart Failure
July 16, 2025
·
2 min read
1 of 85,294
Next
